Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the financial year ended 31st March, 2025
Awaiting price reaction for this filing.
Piramal Pharma Limited has informed the stock exchanges that the audio recording of its conference call held on 15th May, 2025 on the audited standalone and consolidated financial results for the quarter and year ended 31st March, 2025 is now available on the company's website. This is a routine regulatory disclosure made under SEBI's Listing Regulations, following up on an earlier letter dated 29th April, 2025. The filing itself does not contain any financial numbers or management commentary — it only directs investors to the audio link on the piramalpharma.com website. No additional details on performance, outlook, or strategy are provided in this particular letter.
No direct impact on shareholders or stock price from this filing alone. Investors who want to hear management's views on FY25 results and the year ahead should listen to the audio recording on the company's website for any guidance or commentary.